Physician profile
Aldene Doyle
NPI 1215551122
$627.73
in general payments reported to CMS, 2019-2025
16 companies · $204 in 2025
The $204 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $20.49 · 2022: $231 · 2023: $120 · 2024: $51.40 · 2025: $204.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $376.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $375.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $137.98 | 2022-2025 | |
| Solventum Corporation | $63.80 | 2024-2025 | Activ.A.C., V.A.C. Dermatac, V.A.C. Granufoam |
| Tactile Systems Technology INC | $51.89 | 2023 | Entre Plus, Flexitouch Plus |
| Bsn Medical INC | $49.23 | 2022 | |
| Organogenesis INC. | $48.08 | 2025 | Simplimax, Puraply Wound Matrix |
| Integra Lifesciences Corporation | $42.01 | 2022-2025 | Tcc-Ez |
| Hydrofera LLC | $37.70 | 2023 | Hydrofera Blue |
| Novartis Pharmaceuticals Corporation | $36.99 | 2021-2022 | |
| Hartmann USA, INC. | $34.70 | 2022-2025 | Zetuvit Plus 10x10 P10 |
| Urgo Medical North America, LLC | $26.91 | 2025 | Urgok2 |
| Vanda Pharmaceuticals INC. | $20.27 | 2022 | |
| Shield Therapeutics INC | $20.09 | 2022 | |
| Kci USA, INC. | $15.84 | 2023 | Promogran Prisma, Tegaderm, Kerramax Care |
| Medline Industries Lp | $14.94 | 2023 | |
| Lilly USA, LLC | $14.37 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $12.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aldene Doyle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.